Inventor
SUNEEL GUPTA
Inventor
US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
Y02ATechnologies for adaptation to climate change23%
PatentTitleYear
12,491,164Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202512,458,616Levodopa dosing regimen202512,453,710Levodopa dosing regimen202512,447,139Levodopa dosing regimen202512,403,099Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202512,370,163Levodopa dosing regimen202512,303,605Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202512,303,481Levodopa dosing regimen202512,303,482Levodopa dosing regimen202512,295,931Levodopa dosing regimen202512,274,793Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202512,263,148Levodopa dosing regimen202512,263,149Levodopa dosing regimen202512,201,596Levodopa dosing regimen202512,194,150Levodopa dosing regimen202512,178,919Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202412,178,918Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202412,128,141Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof202412,109,185Levodopa dosing regimen202412,064,521Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202411,986,449Levodopa dosing regimen202411,666,538Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202311,622,941Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202311,357,733Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to IMPAX LABORATORIES LLC (11)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to AMNEAL PHARMACEUTICALS LLC (13)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMNEAL PHARMACEUTICALS LLC | 13 | 2024–2025 |
| IMPAX LABORATORIES LLC | 11 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 24 | 2022–2025 |